Rosiglitazone — CAS 122320-73-4

Rosiglitazone is a high-purity Active Pharmaceutical Ingredient (API) classified under Thiazolidinedione / PPARγ Agonist / Antidiabetic. Mediocon Inc manufactures GMP-compliant Rosiglitazone at its state-of-the-art facility in Aurangabad, Maharashtra, India, supplying pharmaceutical companies worldwide with consistent quality and full regulatory documentation.

• Type 2 diabetes mellitus treatment
• PPARγ agonist-mediated insulin sensitization
• Combination antidiabetic therapy
• Metabolic syndrome research

• GMP Certified manufacturing facility in Aurangabad, Maharashtra, India
• Full pharmacopoeial compliance: IP / BP / EP / USP standards
• Complete documentation: Certificate of Analysis (CoA), MSDS, Certificate of Origin
• Stringent in-process quality control at every manufacturing stage
• HPLC purity testing and spectroscopic identification (IR, NMR)
• Cold-chain and controlled-environment storage facilities available
• Exported to 40+ countries with full regulatory support